Please login to the form below

ICS

This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.

on LABA vilanterol, LAMA umeclidinium and ICS fluticasone furoate - in the US and Europe last year.

EMA approves GSK’s triple COPD therapy

moderate to severe COPD who are not adequately treated by the combination of an inhaled corticosteroid (ICS) and a long-acting beta agonist (LABA). ... The same indication was approved by the FDA in September, and makes Trelegy the first drug on the
With US approval, GSK now needs rapid uptake for COPD triple

The three-drug product delivers a long-acting beta agonist (LABA), a long-acting muscarinic antagonist (LAMA) and an inhaled corticosteroid (ICS) from a single device, and is the first product
GSK closes in on EU approval for triple COPD therapy

The new product adds long-acting muscarinic receptor antagonist (LAMA) umeclidinium to the ICS/LABA combination, which has proved so successful in GSK's big-selling Advair/Seretide (fluticasone propionate/salmeterol) ... The benefits of Trelegy/Elebrato -
GSK preps COPD filing for asthma pioneer Nucala

Aside from Nucala, GSK is pinning its near-term hopes on dolutegravir-based HIV therapies and its closed triple therapy for COPD – delivering inhaled corticosteroid (ICS) fluticasone furoate, long-acting beta
Chiesi Group's Trimbow wins European licence

The treatment comprises an inhaled corticosteroid (ICS), long-acting beta2-agonist (LABA) and long-acting muscarinic antagonist (LAMA) in one inhaler and is the such triple combination COPD therapy to be ... Administered twice daily at a fixed dose,

More from news
Approximately 1 fully matching, plus 24 partially matching documents found.

Deal Watch table for August 2014

600. TARIS Biomedical/ Allergan. Company acquisition. LiRIS for interstitial cystitis / bladder pain syndrome (IC/BPS) (phase II).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Raising Awareness: It’s World COPD Day today!

Inhaled corticosteroids (ICS) are another COPD treatment used to reduce inflammation in the lungs. ... Interestingly, no advantage in adding ICS to bronchodilator therapy in patients at low risk of exacerbations has been observed.
Managing local population needs is key for the NHS

year. These plans should “ align key assumptions on income, expenditure, activity and workforce” and system leaders within the ICS are expected to take an “ active role in this process”. ... efficiencies. Conclusion. STPs and the newly emerging
How can pharma engage with key decision-makers in new, collaborative NHS care models?

This has resulted in an increasingly complex, multi-layered healthcare system that is seeing some GPs taking on wide-ranging responsibilities in Integrated Care System (ICS) areas. ... work in an alliance within the ICS.
Large-scale NHS commissioning models require new partnership approach from pharma

Some of the mergers have been entered into voluntarily to help cut costs and ultimately pave the way for the introduction of Accountable or Integrated Care System (ACS/ICS) models; while
IC Consultants Ltd

IC Consultants Ltd. We are the UK’ s leading academic consultancy provider, connecting external organisations to the knowledge and resources of Imperial College London. ... IC Consultants Ltd.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Group Account Director, Healthcare Brand Communications, London: Excellent Package

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Add my company

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...